Safety and Efficacy Evaluation of Two Year Imatinib Treatment in Adjuvant Gastrointestinal Stromal Tumor (GIST)

Clinical trial NCT01172548 · COMPLETED

Trial details

NCT number: NCT01172548
Sponsor: Novartis Pharmaceuticals
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Gastrointestinal Stromal Tumors

Start date: 2008-08-01
Primary completion: 2014-03-01
Enrollment: 132

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.